相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Robust antiviral responses in severe hepatitis flare persist after early retreatment cessation and lead toward hepatitis B surface antigen loss: A proof-of-concept study
Ming-Ling Chang et al.
HEPATOLOGY RESEARCH (2022)
Association Between Severe Serum Alanine Aminotransferase Flares and Hepatitis B e Antigen Seroconversion and HBV DNA Decrease in Untreated Patients With Chronic HBV Infection
Mayur Brahmania et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)
Intranasal vaccination with HBs and HBc protein combined with carboxyl vinyl polymer induces strong neutralizing antibody, anti-HBs IgA, and IFNG response
Takahiro Sanada et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2019)
Serum hepatitis B core-related antigen (HBcrAg) correlates with covalently closed circular DNA transcriptional activity in chronic hepatitis B patients
Barbara Testoni et al.
JOURNAL OF HEPATOLOGY (2019)
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
Norah A. Terrault et al.
HEPATOLOGY (2018)
Treatment of chronic hepatitis B naive patients with a therapeutic vaccine containing HBs and HBc antigens (a randomized, open and treatment controlled phase III clinical trial)
Mamun Al Mahtab et al.
PLOS ONE (2018)
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
JOURNAL OF HEPATOLOGY (2017)
Long-term outcome of inactive and active, low viraemic HBeAg-negative-hepatitis B virus infection: Benign course towards HBsAg clearance
Filippo Oliveri et al.
LIVER INTERNATIONAL (2017)
Chronic hepatitis B: Immunological profile and current therapeutic vaccines in clinical trials
Yadira Lobaina et al.
VACCINE (2017)
Therapeutic vaccination for chronic hepatitis B
Anna D. Kosinska et al.
CURRENT OPINION IN VIROLOGY (2017)
The effect of mucoadhesive excipient on the nasal retention time of and the antibody responses induced by an intranasal influenza vaccine
Shinji Saito et al.
VACCINE (2016)
Reduction of Hepatitis B Surface Antigen Levels and Hepatitis B Surface Antigen Seroclearance in Chronic Hepatitis B Patients Receiving 10 Years of Nucleoside Analogue Therapy
Wai-Kay Seto et al.
HEPATOLOGY (2013)
Long-term hepatitis B surface antigen (HBsAg) kinetics during nucleoside/nucleotide analogue therapy: Finite treatment duration unlikely
Stephane Chevaliez et al.
JOURNAL OF HEPATOLOGY (2013)
Longitudinal Change of HBsAg in HBeAg-negative Patients with Genotype B or C Infection
Tung-Hung Su et al.
PLOS ONE (2013)
Recent progress in mucosal vaccine development: potential and limitations
Nils Lycke
NATURE REVIEWS IMMUNOLOGY (2012)
Three-Year Efficacy and Safety of Tenofovir Disoproxil Fumarate Treatment for Chronic Hepatitis B
E. Jenny Heathcote et al.
GASTROENTEROLOGY (2011)
Hepatitis B Surface Antigen Serum Levels Help to Distinguish Active From Inactive Hepatitis B Virus Genotype D Carriers
Maurizia Rossana Brunetto et al.
GASTROENTEROLOGY (2010)
Phase I clinical trial in healthy adults of a nasal vaccine candidate containing recombinant hepatitis B surface and core antigens
Aristides Aguilar Betancourt et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2007)
In vivo immunization by vaccine therapy following virus suppression by lamivudine: a novel approach for treating patients with chronic hepatitis B
N Horiike et al.
JOURNAL OF CLINICAL VIROLOGY (2005)
Diversity of core antigen epitopes of hepatitis B virus
DM Belnap et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
The role of virus-specific CD8+ cells in liver damage and viral control during persistent hepatitis B virus infection
MK Maini et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
分享论文
